Avanos Medical (AVNS) Proxy filing summary

Executive summary

• Avanos Medical has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP), aiming to accelerate innovation, investment, and growth in the medical device sector.

• The acquisition is positioned as a strategic move to leverage AIP's resources and operational expertise, enhancing Avanos' innovation roadmap and expanding its impact for patients.

• Forward-looking statements highlight the potential benefits of the acquisition, while also noting risks such as timing uncertainties, competing proposals, and possible impacts on relationships with employees, suppliers, and customers.

• The company emphasizes purposeful innovation, patient access, and partnership as core priorities guiding its future direction.

Voting matters and shareholder proposals

• Stockholders will be asked to vote on the proposed acquisition of Avanos Medical by AIP affiliates, as outlined in the forthcoming proxy statement.

• The proxy statement will detail the terms of the merger agreement and any related proposals requiring shareholder approval.

Board of directors and corporate governance

• Directors, executive officers, and other management members may be deemed participants in the proxy solicitation for the acquisition.

• Information on the beneficial ownership of directors and officers will be disclosed in the proxy statement and related SEC filings.